Sort
82,697 grants matching “vaccine development”
HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA
$2,638,379Paula Gonzalez · Fundacion Inciensa · N01 · FY2017 · CA
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,637,545Stephen C Harrison · Boston Children'S Hospital · P01 · FY2017 · AI
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,636,978Weill Medical College Of Cornell Univ · U01 · FY2003 · HL
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
$2,636,665Pamela J Bjorkman · California Institute Of Technology · P01 · FY2014 · AI
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
$2,636,624Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2017 · CA
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
$2,635,377Christopher Parks · International Aids Vaccine Initiative · P01 · FY2018 · AI
SPORE IN BREAST CANCER
$2,634,576University Of Alabama At Birmingham · P50 · FY2001 · CA
San Francisco Bay Clinical Trials Unit
$2,634,428Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2019 · AI
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,633,037Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Influenza and Emerging Infectious Diseases
$2,632,949Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Influenza and Emerging Infectious Diseases
$2,632,754Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,632,704Andrea L Cox · Johns Hopkins University · U19 · FY2021 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,631,174Andrea L Cox · Johns Hopkins University · U19 · FY2022 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,630,987Andrea L Cox · Johns Hopkins University · U19 · FY2024 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,630,982Andrea L Cox · Johns Hopkins University · U19 · FY2023 · AI
Mechanisms of naturally-acquired immunity to malaria
$2,630,010Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Malaria Vaccine: BSAM
$2,629,000Louis Miller · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Nanotechnology enabled quantitative imaging of dendritic cell anti-cancer vaccines
$2,628,974Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2025 · CA
Northwestern University Clinical Trial Unit
$2,628,944Robert L. Murphy · Northwestern University At Chicago · UM1 · FY2012 · AI
Integrative Immunogen Design and Testing
$2,628,877Erica Ollmann Saphire · Brigham And Women'S Hospital · P01 · FY2021 · AI
Structural vaccinology guided development of a universal CoV vaccine utilizing nucleic acid delivered nanoparticles
$2,626,814David B. Weiner · Wistar Institute · P01 · FY2022 · AI
Integrated Support Services
$2,626,784Joan Elizabeth Nichols · University Of Texas Med Br Galveston · UC7 · FY2012 · AI
Understanding Papillomavirus Virion Proteins and Vaccines
$2,626,564John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
The Johns Hopkins University-Blantyre Clinical Trials Unit
$2,626,268Taha E Taha · Johns Hopkins University · UM1 · FY2021 · AI
COVID-19: Assay Development, HTS and Drug Repurposing to identify potential therapeutics against SARS-CoV-2
$2,626,150Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR